A one-day event to be held on 25th April 2008 at the Chiltern Hall, University of Westminster, London, UK

 

This meeting is dedicated to the technique of immunohistochemistry and in situ hybridisation. Presentations by leaders in the field are focused on the technical aspects of IHC as well as the importance of IHC in the areas of drug discovery and diagnosis. Technical and scientific presentations are interspersed with the latest developments from the leading manufacturers of IHC products. 

Chair:  Dr Will Howat, Cambridge Research Institute, Cancer Research UK 

 

Confirmed talks

Quality control for In situ hybridisation

Dr James Pringle, University of Leicester, UK

Immunogold labelling: A review

Dr Jeremy Skepper, University of Cambridge, UK
Multiplexing molecular markers
in vivo and ex vivo with multispectral imaging

James Mansfield, Biomedical Systems, CRI, Inc., USA

 

Confirmed Speakers

Dr Kerry Jackson, Astrazeneca UK
Andy Postoyalko, Covance Laboratories Ltd, Europe, Harrogate, UK

 

 

The deadline for early registration is January 20th 2008.

 

 

For more information go to www.regonline.co.uk/IHC2008

 

 

We seek CPD accreditation from the IBMS for all our meetings

 

 

Improving Immunohistochemistry: 25th April 2008